Jpmorgan Chase & CO Relay Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.22 Trillion
  • Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 5,517,516 shares of RLAY stock, worth $23.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,517,516
Previous 3,963,401 39.21%
Holding current value
$23.1 Million
Previous $25.8 Million 51.17%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Dec 26, 2024
BUY
$6.23 - $9.51 $9.68 Million - $14.8 Million
1,554,115 Added 39.21%
5,517,516 $39.1 Million
Q3 2024

Nov 08, 2024
BUY
$6.23 - $9.51 $9.68 Million - $14.8 Million
1,554,115 Added 39.21%
5,517,516 $39.1 Million
Q2 2024

Dec 26, 2024
SELL
$5.9 - $8.02 $9.17 Million - $12.5 Million
-1,554,115 Reduced 28.17%
3,963,401 $25.8 Million
Q2 2024

Aug 12, 2024
BUY
$5.9 - $8.02 $1.45 Million - $1.97 Million
246,133 Added 6.62%
3,963,401 $25.8 Million
Q1 2024

Dec 26, 2024
SELL
$7.5 - $12.07 $13.5 Million - $21.7 Million
-1,800,248 Reduced 32.63%
3,717,268 $30.9 Million
Q1 2024

May 10, 2024
SELL
$7.5 - $12.07 $17.6 Million - $28.3 Million
-2,348,327 Reduced 38.72%
3,717,268 $30.9 Million
Q4 2023

Dec 26, 2024
BUY
$6.01 - $11.48 $3.29 Million - $6.29 Million
548,079 Added 9.93%
6,065,595 $66.8 Million
Q4 2023

Feb 12, 2024
BUY
$6.01 - $11.48 $5.58 Million - $10.7 Million
929,111 Added 18.09%
6,065,595 $66.8 Million
Q3 2023

Nov 14, 2023
BUY
$8.24 - $12.97 $1.17 Million - $1.84 Million
141,579 Added 2.83%
5,136,484 $43.2 Million
Q2 2023

Aug 11, 2023
BUY
$9.99 - $18.27 $6.93 Million - $12.7 Million
694,079 Added 16.14%
4,994,905 $62.7 Million
Q1 2023

May 18, 2023
BUY
$15.0 - $22.76 $1.73 Million - $2.62 Million
115,187 Added 2.75%
4,300,826 $70.8 Million
Q1 2023

May 11, 2023
SELL
$15.0 - $22.76 $4.26 Million - $6.47 Million
-284,259 Reduced 6.36%
4,185,639 $68.9 Million
Q4 2022

Feb 13, 2023
SELL
$14.16 - $24.02 $7.77 Million - $13.2 Million
-548,589 Reduced 10.93%
4,469,898 $66.8 Million
Q3 2022

Nov 14, 2022
BUY
$18.07 - $31.37 $1.38 Million - $2.39 Million
76,225 Added 1.54%
5,018,487 $112 Million
Q2 2022

Aug 11, 2022
BUY
$13.31 - $34.88 $22.2 Million - $58.2 Million
1,667,873 Added 50.94%
4,942,262 $82.8 Million
Q1 2022

May 11, 2022
SELL
$20.26 - $32.36 $1.88 Million - $3.01 Million
-92,923 Reduced 2.76%
3,274,389 $98 Million
Q4 2021

Feb 10, 2022
BUY
$26.0 - $37.03 $50.4 Million - $71.9 Million
1,940,330 Added 135.97%
3,367,312 $103 Million
Q3 2021

Nov 12, 2021
BUY
$29.75 - $37.99 $42.5 Million - $54.2 Million
1,426,982 New
1,426,982 $45 Million

Others Institutions Holding RLAY

# of Institutions
204
Shares Held
156M
Call Options Held
207K
Put Options Held
40K
View Full List

About Relay Therapeutics, Inc.

RLAY Quotes by TradingView
  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $503M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email